QUREuniQure N.V.

$1B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$464M+30119.4% YoY

Gross Profit

$441M95.0% margin

Operating Income

$398M85.8% margin

Net Income

$399M86.1% margin

EPS (Diluted)

$8.51

QoQ Revenue Growth

+102073.6%

Cash Flow

Operating Cash Flow

$416M

Free Cash Flow

$414M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$784M

Total Liabilities

$151M

Stockholders' Equity

$634M

Cash & Equivalents

$677M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$464M	$2M	+30119.4%
Gross Profit	$441M	$2M	+28609.4%
Operating Income	$398M	-$38M	+1141.7%
Net Income	$399M	-$43M	+1038.8%

Revenue Segments

License

$462M100%

Collaborative Revenue

$1M0%

QURE Q2 2021 Earnings — uniQure N.V. Revenue & Financial Results | Market Cap Arena